Nadege Gunn
About
In The Last Decade
Nadege Gunn
19 papers receiving 572 citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Epidemiology 439
- Hepatology 210
- Endocrinology, Diabetes and Metabolism 188
- Molecular Biology 159
- Surgery 82
Countries citing papers authored by Nadege Gunn
This map shows the geographic impact of Nadege Gunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadege Gunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadege Gunn more than expected).
Fields of papers citing papers by Nadege Gunn
This network shows the impact of papers produced by Nadege Gunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadege Gunn. The network helps show where Nadege Gunn may publish in the future.
Co-authorship network of co-authors of Nadege Gunn
This figure shows the co-authorship network connecting the top 25 collaborators of Nadege Gunn. A scholar is included among the top collaborators of Nadege Gunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadege Gunn. Nadege Gunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 59 | |
| 5 | 65 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 18 | |
| 10 | 24 | |
| 11 | 82 | |
| 12 | Lean Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease. | 1 |
| 13 | Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis breakdown → | 218 |
| 14 | 5 | |
| 15 | 1 | |
| 16 | 2 | |
| 17 | 41 | |
| 18 | 2 | |
| 19 | 23 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.